Anti-inflammatory potential of Phaseolus calcaratus Roxburgh, a oriental medicine, on LPS-stimulated RAW 264.7 macrophages

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 1, 2011, Pages 120-128

  Fang, Minghao ^a   Lee, Seung Youp ^b   Park, Seung Moon ^a   Choi, Ki Choon ^c   Lee, Young Jae ^d,e   Cho, Hyoung Kwon ^d   Cho, Seong Wan ^f   Whang, Wan Kyunn ^e   Lee, Jeong Chae ^a  

^a Chonbuk National University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

^c National Institute of Animal Science   (South Korea)

^d Han Poong Pharmaceutical Co Ltd   (South Korea)

^e Chung Ang University   (South Korea)

^f Konyang University   (South Korea)

Author keywords

anti inflammation; lipopolysaccharide; mitogen activated protein kinase; nuclear factor B; Phaseolus calcaratus R

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIINFLAMMATORY AGENT; CATECHIN 7 O BETA DEXTRO GLUCOPYRANOSIDE; CYCLOOXYGENASE 2; GLUCOPYRANOSIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHASEOLUS CALCARATUS EXTRACT; PLANT EXTRACT; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEAN; CYTOKINE PRODUCTION; DRUG DNA BINDING; DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; ORIENTAL MEDICINE; PHASEOLUS CALCARATUS; PLANT SEED; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MEDICINE, EAST ASIAN TRADITIONAL; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHASEOLUS; PLANT EXTRACTS; SEEDS; SIGNAL TRANSDUCTION;

EID: 78650390158     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01162.x     Document Type: Article

References (44)

1. Hesslinger C, et al. Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans 2009; 37: 886-891.
2. Sung CS, Wong CS,. Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1beta. Acta Anaesthesiol Taiwan 2007; 45: 103-109.
3. Vuolteenaho K, et al. The role of nitric oxide in osteoarthritis. Scand J Rheumatol 2007; 36: 247-258.
4. Kern TS,. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007; 2007: 95103-95116.
5. Kanwar JR, et al. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Cur Med Chem 2009; 16: 2373-2394.
6. Murakami A,. Chemoprevention with phytochemicals targeting inducible nitric oxide synthase. Forum Nutr 2009; 61: 193-203.
7. Sung MJ, et al. Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-kappaB activation in RAW 264.7 cells. Int Immunopharmacol 2009; 9: 319-323.
8. Kang EH, et al. EstA protein, a novel virulence factor of Streptococcus pneumoniae, induces nitric oxide and pro-inflammatory cytokine production in RAW 264.7 macrophages through NF-kappaB/MAPK. Microb Pathog 2009; 47: 196-201.
9. de la Lastra CA, Villegas I,. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005; 49: 405-430.
10. Vafeiadou K, et al. Neuroinflammation and its modulation by flavonoids. Endocr Met Immune Disord Drug Targets 2007; 7: 211-224.
11. Zhao QW, et al. Effects of ethanol extracts from Adzuki bean (Phaseolus angularis Wight.) and Lima bean (Phaseolus lunatus L.) on estrogen and progesterone receptor phenotypes of MCF-7/BOS cells. Phytother Res 2007; 21: 648-652.
12. Son YO, et al. Apoptosis-inducing factor plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Apoptosis 2009; 14: 796-808.
13. Maulik N, et al. An essential role of NF-kappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998; 429: 365-369.
14. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
15. Kujala TS, et al. Phenolics and betacyanins in red beetroot (Beta vulgaris) root: distribution and effect of cold storage on the content of total phenolics and three individual compounds. J Agric Food Chem 2000; 48: 5338-5342.
16. Gyamfi MA, et al. Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries. Gen Pharmacol 1999; 32: 661-667.
17. Seelinger G, et al. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 2008; 74: 1667-1677.
18. Rathee P, et al. Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets 2009; 8: 229-235.
19. Liu J, et al. The effect of pentoxifylline on existing hypersensitivity in a rat model of neuropathy. Anesth Analg 2008; 106: 650-653.
20. Wang S, et al. Studies on chemical constituents from polygonum macrophyllum. Zhong Yao Cai 2004; 27: 411-413.
21. Lee GY, et al. Flavan-3-ols from Ulmus davidiana var. japonica with inhibitory activity on protein glycation. Planta Med 2008; 74: 1800-1802.
22. Benavides A, et al. Catechin derivatives in Jatropha macrantha stems: Characterization and LC/ESI/MS/MS quail-quantitative analysis. J Pharmaceutical Biomed Anal 2006; 40: 639-647.
23. Munhoz CD, et al. Stress-induced neuroinflammation: mechanisms and new pharmacological targets. Braz J Med Biol Res 2008; 41: 1037-1046.
24. Li XA, et al. Nitric oxide, caveolae, and vascular pathology. Cardiovasc Toxicol 2006; 6: 1-13.
25. Cerra MC, Pellegrino D,. Cardiovascular cGMP-generating systems in physiological and pathological conditions. Cur Med Chem 2007; 14: 585-599.
26. Ponnuchamy B, Khalil RA,. Cellular mediators of renal vascular dysfunction in hypertension. Am J Physiol-Reg, Integr Comp Physiol 2009; 296: R1001-R1018.
27. Zhang R, Li S,. COX-2 as a novel target of CRF family peptides' participating in inflammation. Biochem Biophys Res Communi 2009; 382: 483-485.
28. Wagner EF, Nebreda AR,. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9: 537-549.
29. Gaestel M, et al. Protein kinases as small molecule inhibitor targets in inflammation. Cur Med Chem 2007; 14: 2214-2234.
30. Xagorari A, et al. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 2002; 136: 1058-1064.
31. Watters JJ, et al. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J Biol Chem 2002; 277: 9077-9087.
32. Kang JS, et al. Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus. Phytother Res 2008; 22: 883-888.
33. Kim JY, et al. Anti-inflammatory effect of anemarsaponin B isolated from the rhizomes of Anemarrhena asphodeloides in LPS-induced RAW 264.7 macrophages is mediated by negative regulation of the nuclear factor-kappaB and p38 pathways. Food Chem Toxicol 2009; 47: 1610-1617.
34. Yoshimura A,. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 2006; 97: 439-447.
35. Kim YW, et al. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-κB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol 2008; 154: 165-173.
36. Lee HJ, et al. Eutigoside C inhibits the production of inflammatory mediators (NO, PGE(2), IL-6) by down-regulating NF-kappa B and MAP kinase activity in LPS-stimulated RAW 264.7 cells. J Pharm Pharmacol 2008; 60: 917-924.
37. Shin KM, et al. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappa B inactivation. J Pharm Pharmacol 2009; 61: 479-486.
38. Yang EB, et al. Butein, a specific protein tyrosine kinase inhibitor. Biochem Biophys Res Communi 1998; 245: 435-438.
39. Gamet-Payrastre L, et al. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 1999; 32: 279-286. (Pubitemid 29146039)
40. Caltagirone S, et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 2000; 87: 595-600.
41. Ríos JL, et al. Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer. Curr Pharm Des 2009; 15: 1212-1237.
42. Wilson JX,. Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium. Biofactors 2009; 35: 5-13.
43. Heo SK, et al. Ethylacetate extract from Draconis resina inhibits LPS-induced inflammatory responses in vascular smooth muscle cells and macrophages via suppression of ROS production. Food Chem Toxicol 2010; 48: 1129-1136
44. Lee SJ, Lim KT,. Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm Res 2009; 58: 184-191.